Skip to main content

2017 | OriginalPaper | Buchkapitel

26. Kopfsc hmerz bei Medikamenten übergebrauch

verfasst von : Dr. rer. medic. Dipl.-Psych. G. Fritsche

Erschienen in: Schmerzpsychotherapie

Verlag: Springer Berlin Heidelberg

Zusammenfassung

Vermehrte Kopfschmerzen können zu vermehrter Schmerzmitteleinnahme, die vermehrte Einnahme wiederum kann zu Veränderungen im Nervensystem führen. So können sich Strukturen, die für die Aufnahme und Verarbeitung von Schmerz verantwortlich sind, verändern. Dies kann zu einem Ungleichgewicht zwischen schmerzverarbeitenden und schmerzhemmenden System führen, sodass Schmerzreize nicht mehr gut genug unterdrückt werden und die Häufigkeit der Kopfschmerzen zunimmt. Dies wiederum kann zu einem weiteren Anstieg der Medikamenteneinnahme führen, wodurch dann das schmerzverarbeitende System noch empfindlicher wird. Und so kann sich dieser Regelkreis wie eine Spirale in die Höhe schrauben. Die Medikamente helfen dann zwar noch, aber ihre Wirkung wird zunehmend schwächer. Vor allem aber sorgen sie dafür, dass die Kopfschmerzen noch häufiger auftreten.
Literatur
Zurück zum Zitat Aurora S, Dodick D, Turkel C, Degryse R, Silberstein S, Lipton R, Diener HC, Brin MF; PREEMPT 1 Chronic Migraine Study Group (2010) Onabotulinumtoxina for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial. Cephalalgia 30: 793–803 Aurora S, Dodick D, Turkel C, Degryse R, Silberstein S, Lipton R, Diener HC, Brin MF; PREEMPT 1 Chronic Migraine Study Group (2010) Onabotulinumtoxina for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial. Cephalalgia 30: 793–803
Zurück zum Zitat Ayzenberg I, Katsarava Z (2012) Lifting the burden. The prevalence of primary headache disorders in Russia: a countrywide survey. Cephalalgia; 32: 373–381 Ayzenberg I, Katsarava Z (2012) Lifting the burden. The prevalence of primary headache disorders in Russia: a countrywide survey. Cephalalgia; 32: 373–381
Zurück zum Zitat Bahra A, Walsh M, Menon S, Goadsby PJ (2003) Does chronic daily headache arise de novo in association with regular use of analgesics? Headache 43: 179–190 Bahra A, Walsh M, Menon S, Goadsby PJ (2003) Does chronic daily headache arise de novo in association with regular use of analgesics? Headache 43: 179–190
Zurück zum Zitat Bigal ME, Lipton RB (2008) Excessive acute migraine medication use and migraine progression. Neurology 71: 1821–1828 Bigal ME, Lipton RB (2008) Excessive acute migraine medication use and migraine progression. Neurology 71: 1821–1828
Zurück zum Zitat Boe MG, Mygland A, Salvesen R (2007) Prednisolone does not reduce withdrawal headache: a randomized, double-blind study. Neurology 69: 26–31 Boe MG, Mygland A, Salvesen R (2007) Prednisolone does not reduce withdrawal headache: a randomized, double-blind study. Neurology 69: 26–31
Zurück zum Zitat Diener HC (2012) Detoxification for medication overuse headache is not necessary. Cephalalgia 32: 423–427 Diener HC (2012) Detoxification for medication overuse headache is not necessary. Cephalalgia 32: 423–427
Zurück zum Zitat Diener HC, Dahlöf C (2000) Headache associated with chronic use of substances. In: Olesen J, Tfelt-Hansen P, Welch KMA (eds) The Headaches, 2nd ed. Lippincott, Williams & Wilkins, Philadelphia, pp 871–878 Diener HC, Dahlöf C (2000) Headache associated with chronic use of substances. In: Olesen J, Tfelt-Hansen P, Welch KMA (eds) The Headaches, 2nd ed. Lippincott, Williams & Wilkins, Philadelphia, pp 871–878
Zurück zum Zitat Diener HC, Limmroth V (2004) Medication-overuse headache: a worldwide problem. Lancet Neurology 3: 475–483 Diener HC, Limmroth V (2004) Medication-overuse headache: a worldwide problem. Lancet Neurology 3: 475–483
Zurück zum Zitat Diener HC, Slomke MA, Limmroth V (2007a) Headache and migraine. Nervenarzt 78 (Suppl 1): 7–13 Diener HC, Slomke MA, Limmroth V (2007a) Headache and migraine. Nervenarzt 78 (Suppl 1): 7–13
Zurück zum Zitat Diener H, Bussone G, Van Oene J, Lahaye M, Schwalen S, Goadsby P; TOPMAT-MIG-201(TOP-CHROME) Study Group (2007b) Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study. Cephalalgia 27: 814–823 Diener H, Bussone G, Van Oene J, Lahaye M, Schwalen S, Goadsby P; TOPMAT-MIG-201(TOP-CHROME) Study Group (2007b) Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study. Cephalalgia 27: 814–823
Zurück zum Zitat Diener H, Dodick D, Goadsby P, Bigal M, Bussone G, Silberstein S, Mathew N, Ascher S, Morein J, Hulihan JF, Biondi DM, Greenberg SJ (2009) Utility of topiramate for the treatment of patients with chronic migraine in the presence or absence of acute medication overuse. Cephalalgia 29: 1021–1027 Diener H, Dodick D, Goadsby P, Bigal M, Bussone G, Silberstein S, Mathew N, Ascher S, Morein J, Hulihan JF, Biondi DM, Greenberg SJ (2009) Utility of topiramate for the treatment of patients with chronic migraine in the presence or absence of acute medication overuse. Cephalalgia 29: 1021–1027
Zurück zum Zitat Diener H, Dodick D, Aurora S, Turkel C, Degryse R, Lipton R, Silberstein SD, Brin MF; PREEMPT 2 Chronic Migraine Study Group (2010) Onabotulinumtoxina for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial. Cephalalgia 30: 804–814 Diener H, Dodick D, Aurora S, Turkel C, Degryse R, Lipton R, Silberstein SD, Brin MF; PREEMPT 2 Chronic Migraine Study Group (2010) Onabotulinumtoxina for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial. Cephalalgia 30: 804–814
Zurück zum Zitat Dodick D, Turkel C, Degryse R, Aurora S, Silberstein S, Lipton R, Diener HC, Brin MF; PREEMPT Chronic Migraine Study Group (2010) Onabotulinumtoxina for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT Clinical Program. Headache 50: 921–936 Dodick D, Turkel C, Degryse R, Aurora S, Silberstein S, Lipton R, Diener HC, Brin MF; PREEMPT Chronic Migraine Study Group (2010) Onabotulinumtoxina for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT Clinical Program. Headache 50: 921–936
Zurück zum Zitat Evers S, Marziniak M (2010) Clinical features, pathophysiology, and treatment of medication-overuse headache. Lancet Neurol 9: 391–401 Evers S, Marziniak M (2010) Clinical features, pathophysiology, and treatment of medication-overuse headache. Lancet Neurol 9: 391–401
Zurück zum Zitat Fritsche G (2013) Spezielle Aspekte der psychologischen Exploration von Kopfschmerzpatienten. In: Fritsche G, Gaul C (Hrsg) Multimodale Therapie bei chronischen Kopfschmerzen. Thieme, Stuttgart, S 31–32 Fritsche G (2013) Spezielle Aspekte der psychologischen Exploration von Kopfschmerzpatienten. In: Fritsche G, Gaul C (Hrsg) Multimodale Therapie bei chronischen Kopfschmerzen. Thieme, Stuttgart, S 31–32
Zurück zum Zitat Fritsche G, Diener HC (2002) Medication overuse headaches – what is new? Expert Opin Drug Saf 1: 331–338 Fritsche G, Diener HC (2002) Medication overuse headaches – what is new? Expert Opin Drug Saf 1: 331–338
Zurück zum Zitat Fritsche G, Nitsch C, Pietrowsky R, Diener HC (2000) Psychologische Deskriptoren des Schmerzmittelabusus und des medikamenteninduzierten Kopfschmerzes. Schmerz 14: 217–255 Fritsche G, Nitsch C, Pietrowsky R, Diener HC (2000) Psychologische Deskriptoren des Schmerzmittelabusus und des medikamenteninduzierten Kopfschmerzes. Schmerz 14: 217–255
Zurück zum Zitat Fritsche G, Eberl A, Katsarava Z, Limmroth V, Diener HC (2001) Drug-induced headache: long-term follow-up of withdrawal therapy and persistence of drug misuse. Eur Neurol 45: 229–235 Fritsche G, Eberl A, Katsarava Z, Limmroth V, Diener HC (2001) Drug-induced headache: long-term follow-up of withdrawal therapy and persistence of drug misuse. Eur Neurol 45: 229–235
Zurück zum Zitat Fritsche G, Frettlöh J, Hüppe M, Dlugaj M, Matatko N, Gaul C, Diener HC; Study Group (2010) Prevention of medication overuse in patients with migraine. Pain 151: 404–413 Fritsche G, Frettlöh J, Hüppe M, Dlugaj M, Matatko N, Gaul C, Diener HC; Study Group (2010) Prevention of medication overuse in patients with migraine. Pain 151: 404–413
Zurück zum Zitat Gaist D, Hallas J, Sindrup SH, Gram LF (1996) Is overuse of sumatriptan a problem? A population-based study. Eur J Clin Pharmacol 3: 161–165 Gaist D, Hallas J, Sindrup SH, Gram LF (1996) Is overuse of sumatriptan a problem? A population-based study. Eur J Clin Pharmacol 3: 161–165
Zurück zum Zitat Gaul C, Liesering-Latta E, Schäfer B, Fritsche G, Holle D (2015) Integrated multidisciplinary care of headache disorders: A narrative review. Cephalalgia. doi: 10.1177/ 0333102415617413 Gaul C, Liesering-Latta E, Schäfer B, Fritsche G, Holle D (2015) Integrated multidisciplinary care of headache disorders: A narrative review. Cephalalgia. doi: 10.1177/ 0333102415617413
Zurück zum Zitat Grande R, Aaseth K, Benth J, Lundqvist C, Russell M (2011) Reduction in Medication-overuse headache after short information. The Akershus Study of Chronic Headache. Eur J Neurol 18: 129–137 Grande R, Aaseth K, Benth J, Lundqvist C, Russell M (2011) Reduction in Medication-overuse headache after short information. The Akershus Study of Chronic Headache. Eur J Neurol 18: 129–137
Zurück zum Zitat Haag G, Fritsche G, Gaul C (2013) Klinik und Pathogenese des Kopfschmerzes bei Medikamentenübergebrauch. In: Fritsche G, Gaul C (Hrsg) Multimodale Therapie bei chronischen Kopfschmerzen. Thieme, Stuttgart, S 50–53 Haag G, Fritsche G, Gaul C (2013) Klinik und Pathogenese des Kopfschmerzes bei Medikamentenübergebrauch. In: Fritsche G, Gaul C (Hrsg) Multimodale Therapie bei chronischen Kopfschmerzen. Thieme, Stuttgart, S 50–53
Zurück zum Zitat Hagen K, Albretsen C, Vilming ST, Salvesen R, Grønning M, Helde G, Gravdahl G, Zwart JA, Stovner LJ (2009) Management of medication overuse headache: 1-year randomized multicentre open-label trial. Cephalalgia 29: 221–232 Hagen K, Albretsen C, Vilming ST, Salvesen R, Grønning M, Helde G, Gravdahl G, Zwart JA, Stovner LJ (2009) Management of medication overuse headache: 1-year randomized multicentre open-label trial. Cephalalgia 29: 221–232
Zurück zum Zitat Hagen K, Linde M, Steiner TJ, Stovner LJ, Zwart JA (2012) Risk factors for medication-overuse headache: an 11-year follow-up study. The Nord-Trøndelag Health Studies. Pain 153: 56–61 Hagen K, Linde M, Steiner TJ, Stovner LJ, Zwart JA (2012) Risk factors for medication-overuse headache: an 11-year follow-up study. The Nord-Trøndelag Health Studies. Pain 153: 56–61
Zurück zum Zitat IHS – Headache Classification Committee of the International Headache Society (2004) The International Classification of Headache Disorders, 2nd ed. ICHD-II. Cephalalgia 24 (Suppl 1): 1–160 IHS – Headache Classification Committee of the International Headache Society (2004) The International Classification of Headache Disorders, 2nd ed. ICHD-II. Cephalalgia 24 (Suppl 1): 1–160
Zurück zum Zitat IHS – Headache Classification Committee of the International Headache Society (2013) The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 33: 629–808 IHS – Headache Classification Committee of the International Headache Society (2013) The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 33: 629–808
Zurück zum Zitat Jage J, Willweber-Strumpf A, Maier C (2005) Risk factors for substance abuse and dependence in opioid therapy for chronic noncancer-related pain. Schmerz 19: 434–440 Jage J, Willweber-Strumpf A, Maier C (2005) Risk factors for substance abuse and dependence in opioid therapy for chronic noncancer-related pain. Schmerz 19: 434–440
Zurück zum Zitat Katsarava Z, Diener HC (2003) Medikamenteninduzierte Kopfschmerzen. In: Diener HC (Hrsg) Kopfschmerzen – Referenzreihe Neurologie. Thieme, Stuttgart, S 213–228 Katsarava Z, Diener HC (2003) Medikamenteninduzierte Kopfschmerzen. In: Diener HC (Hrsg) Kopfschmerzen – Referenzreihe Neurologie. Thieme, Stuttgart, S 213–228
Zurück zum Zitat Katsarava Z, Jensen R (2007) Medication-overuse headache: where are we now? Curr Opin Neurol 20: 326–330 Katsarava Z, Jensen R (2007) Medication-overuse headache: where are we now? Curr Opin Neurol 20: 326–330
Zurück zum Zitat Katsarava Z, Obermann M (2013) Medication-overuse headache. Curr Opin Neurol 26: 276–281 Katsarava Z, Obermann M (2013) Medication-overuse headache. Curr Opin Neurol 26: 276–281
Zurück zum Zitat Katsarava Z, Fritsche G, Muessig M, Diener HC, Limmroth V (2001) Clinical features of withdrawal headache following overuse of triptans and other headache drugs. Neurology 57: 1694–1698 Katsarava Z, Fritsche G, Muessig M, Diener HC, Limmroth V (2001) Clinical features of withdrawal headache following overuse of triptans and other headache drugs. Neurology 57: 1694–1698
Zurück zum Zitat Katsarava Z, Limmroth V, Finke M, Diener HC, Fritsche G (2003) Rates and predictors for relapse in medication overuse headache: a 1-year prospective study. Neurology 60: 1682–1683 Katsarava Z, Limmroth V, Finke M, Diener HC, Fritsche G (2003) Rates and predictors for relapse in medication overuse headache: a 1-year prospective study. Neurology 60: 1682–1683
Zurück zum Zitat Katsarava Z, Schneeweiss S, Kurth T, Kroener U, Fritsche G, Eikermann A, Diener HC, Limmroth V (2004) Incidence and predictors for chronicity of headache in patients with episodic migraine. Neurology 62: 788–790 Katsarava Z, Schneeweiss S, Kurth T, Kroener U, Fritsche G, Eikermann A, Diener HC, Limmroth V (2004) Incidence and predictors for chronicity of headache in patients with episodic migraine. Neurology 62: 788–790
Zurück zum Zitat Katsarava Z, Holle D, Diener HC (2009) Medication over- use headache. Curr Neurol Neurosci Rep 9: 115–119 Katsarava Z, Holle D, Diener HC (2009) Medication over- use headache. Curr Neurol Neurosci Rep 9: 115–119
Zurück zum Zitat Krymchantowski AV, Moreira PF (2003) Out-patient detoxification in chronic migraine: comparison of strategies. Cephalalgia 23: 982–993 Krymchantowski AV, Moreira PF (2003) Out-patient detoxification in chronic migraine: comparison of strategies. Cephalalgia 23: 982–993
Zurück zum Zitat Limmroth V, Katsarava Z, Fritsche G, Przywara S, Diener HC (2002) Features of medication overuse headache following overuse of different acute headache drugs. Neurology 59: 1011–1014 Limmroth V, Katsarava Z, Fritsche G, Przywara S, Diener HC (2002) Features of medication overuse headache following overuse of different acute headache drugs. Neurology 59: 1011–1014
Zurück zum Zitat Linde M, Gustavsson A, Stovner LJ, Steiner TJ, Barré J, Katsarava Z, Lainez JM, Lampl C, Lantéri-Minet M, Rastenyte D, Ruiz de la Torre E, Tassorelli C, Andrée C (2012) The cost of headache disorders in Europe: The Eurolight project. Eur J Neurol 19: 703–711 Linde M, Gustavsson A, Stovner LJ, Steiner TJ, Barré J, Katsarava Z, Lainez JM, Lampl C, Lantéri-Minet M, Rastenyte D, Ruiz de la Torre E, Tassorelli C, Andrée C (2012) The cost of headache disorders in Europe: The Eurolight project. Eur J Neurol 19: 703–711
Zurück zum Zitat Lundqvist C, Grande RB, Aaseth K, Russell MB (2012) Dependence scores predict prognosis of medication overuse headache: a prospective cohort from the Akershus study of chronic headache. Pain 153: 682–686 Lundqvist C, Grande RB, Aaseth K, Russell MB (2012) Dependence scores predict prognosis of medication overuse headache: a prospective cohort from the Akershus study of chronic headache. Pain 153: 682–686
Zurück zum Zitat Munksgaard SB, Jensen RH (2014) Medication overuse headache. Headache 54: 1251–1257 Munksgaard SB, Jensen RH (2014) Medication overuse headache. Headache 54: 1251–1257
Zurück zum Zitat Munksgaard S, Bendtsen L, Jensen R (2012) Detoxification of medication-overuse headache by a multidisciplinary treatment programme is highly effective: a comparison of two consecutive treatment methods in an open-label design. Cephalalgia 32: 834–844 Munksgaard S, Bendtsen L, Jensen R (2012) Detoxification of medication-overuse headache by a multidisciplinary treatment programme is highly effective: a comparison of two consecutive treatment methods in an open-label design. Cephalalgia 32: 834–844
Zurück zum Zitat Pageler L, Katsarava Z, Diener HC, Limmroth V (2008) Prednisone vs. placebo in withdrawal therapy following medication overuse headache. Cephalalgia 28: 152–156 Pageler L, Katsarava Z, Diener HC, Limmroth V (2008) Prednisone vs. placebo in withdrawal therapy following medication overuse headache. Cephalalgia 28: 152–156
Zurück zum Zitat Queiroz LP, Peres MF, Kowacs F, Piovesan EJ, Ciciarelli MC, Souza JA, Zukerman E (2008) Chronic daily headache in Brazil: a nationwide population-based study. Cephalalgia 28:1264–1269 Queiroz LP, Peres MF, Kowacs F, Piovesan EJ, Ciciarelli MC, Souza JA, Zukerman E (2008) Chronic daily headache in Brazil: a nationwide population-based study. Cephalalgia 28:1264–1269
Zurück zum Zitat Rabe K, Pageler L, Gaul C, Lampl C, Kraya T, Foerderreuther S, Diener HC, Katsarava Z (2013) Prednisone for the treatment of withdrawal headache in patients with medication overuse headache: a randomized, double-blind, placebo-controlled study. Cephalalgia 33: 202–207 Rabe K, Pageler L, Gaul C, Lampl C, Kraya T, Foerderreuther S, Diener HC, Katsarava Z (2013) Prednisone for the treatment of withdrawal headache in patients with medication overuse headache: a randomized, double-blind, placebo-controlled study. Cephalalgia 33: 202–207
Zurück zum Zitat Rossi P, Di Lorenzo C, Faroni J, Cesarino F, Nappi G (2006) Advice alone vs. structured detoxification programmes for medication overuse headache: a prospective, randomized, open-label trial in transformed migraine patients with low medical needs. Cephalalgia 26: 1097–1105 Rossi P, Di Lorenzo C, Faroni J, Cesarino F, Nappi G (2006) Advice alone vs. structured detoxification programmes for medication overuse headache: a prospective, randomized, open-label trial in transformed migraine patients with low medical needs. Cephalalgia 26: 1097–1105
Zurück zum Zitat Rossi P, Faroni JV, Nappi G (2011) Short-term effectiveness of simple advice as a withdrawal strategy in simple and complicated medication overuse headache. Eur J Neurol 18: 396–401 Rossi P, Faroni JV, Nappi G (2011) Short-term effectiveness of simple advice as a withdrawal strategy in simple and complicated medication overuse headache. Eur J Neurol 18: 396–401
Zurück zum Zitat Sandrini G, Perrotta A, Tassorelli C, Torelli P, Brighina F, Sances G, Nappi G (2011) Botulinum toxin type-A in the prophylactic treatment of medication overuse headache: a multicenter, double-blind, randomized, placebo-controlled, parallel group study. J Headache Pain 12: 427–433 Sandrini G, Perrotta A, Tassorelli C, Torelli P, Brighina F, Sances G, Nappi G (2011) Botulinum toxin type-A in the prophylactic treatment of medication overuse headache: a multicenter, double-blind, randomized, placebo-controlled, parallel group study. J Headache Pain 12: 427–433
Zurück zum Zitat Scher AI, Stewart WF, Ricci JA, Lipton RB (2003) Factors associated with the onset and remission of chronic daily headache in a population-based study. Pain 106: 81–89 Scher AI, Stewart WF, Ricci JA, Lipton RB (2003) Factors associated with the onset and remission of chronic daily headache in a population-based study. Pain 106: 81–89
Zurück zum Zitat Silverman K, Evans SM, Strain EC, Griffiths RR (1992) Withdrawal syndrome after the double-blind cessation of caffeine consumption. N Engl J Med 327: 1109–1114 Silverman K, Evans SM, Strain EC, Griffiths RR (1992) Withdrawal syndrome after the double-blind cessation of caffeine consumption. N Engl J Med 327: 1109–1114
Zurück zum Zitat Steiner TJ, Paemeleire K, Jensen R, Valade D, Savi L, Lainez MJ, Diener HC, Martelletti P, Couturier EG, European Headache Federation, Lifting The Burden, The Global Campaign to Reduce the Burden of Headache Worldwide, World Health Organization (2007) European principles of management of common headache disorders in primary care. J Headache Pain 8 (Suppl 1): S3–S47 Steiner TJ, Paemeleire K, Jensen R, Valade D, Savi L, Lainez MJ, Diener HC, Martelletti P, Couturier EG, European Headache Federation, Lifting The Burden, The Global Campaign to Reduce the Burden of Headache Worldwide, World Health Organization (2007) European principles of management of common headache disorders in primary care. J Headache Pain 8 (Suppl 1): S3–S47
Metadaten
Titel
Kopfsc hmerz bei Medikamenten übergebrauch
verfasst von
Dr. rer. medic. Dipl.-Psych. G. Fritsche
Copyright-Jahr
2017
Verlag
Springer Berlin Heidelberg
DOI
https://doi.org/10.1007/978-3-662-50512-0_26

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.